10-13-2017 09:47 AM CET - Health & Medicine
Print

Radiopharmaceuticals Market $376 Million by 2021

Press release from: iHealthcareAnalyst, Inc.

Radiopharmaceuticals Market Analysis and Forecast 2017-2021 report estimates the global radiopharmaceuticals market to reach nearly $376 Million in 2021, at a CAGR of 4.9% from 2017 to 2021 - iHealthcareAnalyst, Inc.

The global radiopharmaceuticals market report estimates the market size (Revenue $million - 2014 to 2021) for key market segments based on the indications (cardiovascular, oncology, neurological, thyroid, gastrointestinal, etc.), therapeutics (systemic oncology using Iodine, Yttrium, Samarium, Strontium, Rhenium, Lutetium, Erbium; cardiology, neurology, etc.), technologies (SPECT – Technetium, Thallium, Gallium, Iodine, Rhenium, Yttrium; PET - Fludeoxyglucose, Rubidium, Carbon-11 Choline, Nitrogen-13 Ammonia, etc.), generators (Mo-99/Tc-99m, Sr-82/Rb-82, Ge-68/Ga-68, Sr-90/Y-90, and W-188/Re-188 generators), end users (diagnostic centers, hospitals and medical centers), and forecasts growth trends (CAGR% - 2017 to 2021).

The global radiopharmaceuticals market report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends.

Visit the Radiopharmaceuticals Market Analysis and Forecast 2017-2021 report www.ihealthcareanalyst.com/report/radiopharmaceuticals-ma...

1. Indication
1.1. Cardiovascular
1.2. Oncology
1.3. Others (Neurological, Thyroid, Gastrointestinal)

2. Therapy
2.1. Systemic Oncology
2.1.1. Iodine (I-131)
2.1.2. Yttrium (90Y)
2.1.3. Samarium (Sm-153)
2.1.4. Strontium (89Sr)
2.1.5. Rhenium (186Re)
2.1.6. Lutetium (Lu-177)
2.1.7. Erbium (169Er)
2.1.8. Others
2.2. Others (Cardiology, Neurology)

3. Technology
3.1. Single-Photon Emission Computed Tomography (SPECT)
3.1.1. Technetium (Tc-99m)
3.1.2. Thallium (TI-201)
3.1.3. Gallium (Ga-67)
3.1.4. Iodine (I-123)
3.1.5. Rhenium (Re-186)
3.1.6. Yttrium (Y-90)
3.1.7. Others
3.2. Positron Emission Tomography (PET)
3.2.1. Fludeoxyglucose (18F-FDG)
3.2.2. Rubidium (Rb-82)
3.2.3. Others (Carbon-11 Choline, Nitrogen-13 Ammonia)

4. Generator Type
4.1. Mo-99/Tc-99m Generator
4.2. Sr-82/Rb-82 Generator
4.3. Ge-68/Ga-68 Generator
4.4. Sr-90/Y-90 Generator
4.5. W-188/Re-188 Generator

5. End User
5.1. Diagnostic Centers
5.2. Hospitals & Medical Centers

6. Company Profiles
6.1. Cardinal Health Inc.
6.2. Covidien Plc
6.3. GE Healthcare
6.4. IBA Group
6.5. Lantheus Medical Imaging
6.6. Monrol Nuclear Products, Inc.
6.7. Nordion, Inc.
6.8. NTP Radioisotopes Ltd.
6.9. Polatom
6.10. Positron Corporation
6.11. Siemens Healthcare

To request Table of Contents and Sample Pages of this report visit:
www.ihealthcareanalyst.com/report/radiopharmaceuticals-ma...

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: www.ihealthcareanalyst.com

This release was published on openPR.
News-ID: 771346 • Views: 142
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.

You can edit or delete your press release here: